Meet-the-Experts
EXCERPTS FROM THE ROUNDTABLE DISCUSSION
September 29, 2005, Charlottesville, VA, U.S.A.
“Preventing the Next CVD Event in Diabetics”
Find answers to the clinically most relevant questions and learn about cutting-edge research data in a "golden hour" of interaction with a multi-specialty team of experts.
(Select a topic below to view it in Windows Media format) 
-
Robert S. Gibson, M.D. "What is the optimal LDL level for diabetics ?"
-
Christopher M. Rembold, M.D. "TZDs and lipids: Is there a class effect ?"
-
Eugene J. Barrett, M.D., Ph.D. "Diabetes mellitus: What is the unifying basis of this vascular disease ?"
-
Murat Tuzcu, M.D. "Coronary atherosclerosis progression in diabetics: What does IVUS show ?"
-
Anthony L. McCall, M.D., Ph.D. "Does glycemia matter to CVD ?"
-
Alan H. Matsumoto, M.D. "The diabetic foot ulcer: Can we obviate extremity amputation ?"
-
Mark D. Okusa, M.D. "Which antihypertensive drugs to use in the patient with CKD ?"
-
Robert M. Carey, M.D. "What combination of therapeutic approaches provides the best level of tissue protection in diabetics ?"
Hosted by the UVA Diabetes Center and Center for Global Health
Supported by Takeda Pharmaceuticals North America, Inc.